[go: up one dir, main page]

TNSN91041A1 - Nouveaux produits chimiques - Google Patents

Nouveaux produits chimiques

Info

Publication number
TNSN91041A1
TNSN91041A1 TNTNSN91041A TNSN91041A TNSN91041A1 TN SN91041 A1 TNSN91041 A1 TN SN91041A1 TN TNSN91041 A TNTNSN91041 A TN TNSN91041A TN SN91041 A TNSN91041 A TN SN91041A TN SN91041 A1 TNSN91041 A1 TN SN91041A1
Authority
TN
Tunisia
Prior art keywords
new
relates
dna sequences
proteins
plasmids
Prior art date
Application number
TNTNSN91041A
Other languages
English (en)
Inventor
Bjursell Gunnar
Blackberg Lars
Carlsson Peter
Enerback Sven
Hernell Olle
Nilsson Jeanette
Olivecrona Thomas
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of TNSN91041A1 publication Critical patent/TNSN91041A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • C12N9/20—Triglyceride splitting, e.g. by means of lipase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures
    • A61K2800/596—Mixtures of surface active compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENTION SE RAPPORTE A DE NOUVELLES SEQUENCES D'ADN, A DE NOUVELLES PROTEINES CODEES PAR LES DITES NOUVELLES SEQUENCES D'ADN, A L'EMPLOI TEL QUE DECRIT DES DITES PROTEINES. L'INVENTION PORTE EGALEMENT SUR DES VECTEURS TELS QUE PLASMIDES CONTENANT LES DITES SEQUENCES D'ADN ET QUI SONT CAPABLES D'EXPRIMER L'ENZYME SOUHAITEE. L'INVENTION PORTE EGALEMENT SUR LES ORGANISMES HOTES TRANSFECTES PAR CES PLASMIDES, PAR EXEMPLE LEVURE DE BACTERIES, CELLULES DE MAMMIFERES, ET ANIMAUX TRANSGENIQUE. L'INVENTION SE RAPPORTE EGALEMENT AUX PROCEDES DE PREPARATION DES NOUVEAUX PRODUITS DE L'INVENTION. LES NOUVELLES PROTEINES DE L'INVENTION SONT APPARENTEES A UNE ENZYME CONNUE EN PARTICULIER SOUS LA DESIGNATION DE LIPASE HUMAINE STIMULEE PAR SELS BILIAIRES
TNTNSN91041A 1990-06-01 1991-05-31 Nouveaux produits chimiques TNSN91041A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9001985A SE9001985D0 (sv) 1990-06-01 1990-06-01 New chemical products

Publications (1)

Publication Number Publication Date
TNSN91041A1 true TNSN91041A1 (fr) 1992-10-25

Family

ID=20379662

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN91041A TNSN91041A1 (fr) 1990-06-01 1991-05-31 Nouveaux produits chimiques

Country Status (44)

Country Link
EP (1) EP0535048B1 (fr)
JP (1) JPH05507201A (fr)
KR (1) KR100212411B1 (fr)
CN (2) CN1075113C (fr)
AP (1) AP207A (fr)
AT (1) ATE151077T1 (fr)
AU (1) AU651979B2 (fr)
BG (1) BG61165B1 (fr)
CA (1) CA2083396C (fr)
CZ (1) CZ287470B6 (fr)
DE (1) DE69125489T2 (fr)
DK (1) DK0535048T3 (fr)
DZ (1) DZ1503A1 (fr)
EG (1) EG19937A (fr)
ES (1) ES2099159T3 (fr)
FI (1) FI114639B (fr)
GR (1) GR3023618T3 (fr)
HK (1) HK62497A (fr)
HR (1) HRP920771B1 (fr)
HU (1) HU215258B (fr)
IE (1) IE911844A1 (fr)
IL (1) IL98273A (fr)
IS (1) IS1751B (fr)
JO (1) JO1694B1 (fr)
LT (1) LT4020B (fr)
LV (1) LV10292B (fr)
MA (1) MA22166A1 (fr)
MY (1) MY111245A (fr)
NO (1) NO322962B1 (fr)
NZ (1) NZ238223A (fr)
PH (1) PH30761A (fr)
PL (1) PL166534B1 (fr)
PT (1) PT97836B (fr)
RO (1) RO114793B1 (fr)
RU (1) RU2140983C1 (fr)
SE (1) SE9001985D0 (fr)
SG (1) SG48078A1 (fr)
SK (1) SK281089B6 (fr)
TN (1) TNSN91041A1 (fr)
TW (1) TW221712B (fr)
UA (1) UA39165C2 (fr)
WO (1) WO1991018923A1 (fr)
YU (1) YU49138B (fr)
ZA (1) ZA913778B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616483A (en) * 1992-06-11 1997-04-01 Aktiebolaget Astra Genomic DNA sequences encoding human BSSL/CEL
IS4130A (is) * 1993-03-01 1994-09-02 Ab Astra Ný fjölpeptíð
SE9300686D0 (sv) 1993-03-01 1993-03-01 Astra Ab Novel polypeptides
FR2754827B1 (fr) * 1996-10-17 1998-12-24 Biocem Lipases pancreatiques et/ou colipases recombinantes et polypeptides dervies produits par les plantes, leurs procedes d'obtention et leurs utilisations
JP2000026311A (ja) * 1998-07-02 2000-01-25 Amano Pharmaceut Co Ltd 胃排出能亢進剤組成物
EP1963524A2 (fr) * 2005-12-01 2008-09-03 University of Bergen Diagnostic et traitement des dysfonctionnements de l'exocrine pancreas et des diabetes
HUE033217T2 (hu) 2010-04-23 2017-11-28 Alexion Pharma Inc Lizoszomális tárolási betegséggel asszociált enzim
ME02062B (me) 2010-09-09 2015-05-20 Synageva Biopharma Corp Primena lizozomalne kisele lipaze za lecenje nedostatka lizozomalne kisele lipaze kod pacijenata
CA2812852A1 (fr) 2010-10-21 2012-04-26 Swedish Orphan Biovitrum Ab (Publ) Procede pour augmenter l'absorption d'acides gras insatures par des nourrissons humains
CN103200957A (zh) 2010-10-21 2013-07-10 瑞典孤儿比奥维特鲁姆有限公司 提高人婴儿之生长速度的方法
CA3066521A1 (fr) 2017-06-19 2018-12-27 Swedish Orphan Biovitrum Ab (Publ) Proteine de fusion presentant un polypeptide d'extension de demi-vie
EP4501403A3 (fr) 2019-08-30 2025-05-14 Société des Produits Nestlé S.A. Variantes de lipase modifiées

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60501758A (ja) * 1983-07-01 1985-10-17 セルテク　リミテツド タンパク質、医薬構成物、遺伝子、ベクタ−宿主生物及びそれらの生産方法

Also Published As

Publication number Publication date
IL98273A (en) 2005-11-20
EP0535048B1 (fr) 1997-04-02
RU2140983C1 (ru) 1999-11-10
NO924528D0 (no) 1992-11-24
AU7964591A (en) 1991-12-31
TW221712B (fr) 1994-03-11
HK62497A (en) 1997-05-16
PT97836B (pt) 1998-11-30
CA2083396A1 (fr) 1991-12-02
PL166534B1 (pl) 1995-05-31
HUT63184A (en) 1993-07-28
FI925453A0 (fi) 1992-11-30
HU9203774D0 (en) 1993-03-29
IE911844A1 (en) 1991-12-04
DZ1503A1 (fr) 2004-09-13
AU651979B2 (en) 1994-08-11
BG61165B1 (bg) 1997-01-31
PH30761A (en) 1997-10-17
DE69125489D1 (de) 1997-05-07
RO114793B1 (ro) 1999-07-30
CN1326782A (zh) 2001-12-19
JO1694B1 (en) 1992-08-09
YU49138B (sh) 2004-03-12
ATE151077T1 (de) 1997-04-15
NO924528L (no) 1992-11-24
LV10292A (lv) 1994-10-20
EP0535048A1 (fr) 1993-04-07
LV10292B (en) 1995-08-20
SE9001985D0 (sv) 1990-06-01
SG48078A1 (en) 1998-04-17
PT97836A (pt) 1992-02-28
JPH05507201A (ja) 1993-10-21
WO1991018923A1 (fr) 1991-12-12
GR3023618T3 (en) 1997-08-29
HRP920771B1 (en) 1999-10-31
HRP920771A2 (en) 1997-04-30
IS3710A7 (is) 1991-12-02
UA39165C2 (uk) 2001-06-15
DK0535048T3 (da) 1997-09-29
AP207A (en) 1992-08-18
LT4020B (en) 1996-08-26
NZ238223A (en) 1993-05-26
MY111245A (en) 1999-10-30
CZ164491A3 (cs) 1999-07-14
SK164491A3 (en) 1995-07-11
CZ287470B6 (cs) 2000-12-13
MA22166A1 (fr) 1991-12-31
DE69125489T2 (de) 1997-08-14
FI114639B (fi) 2004-11-30
LTIP1736A (en) 1995-08-25
YU95191A (sh) 1994-06-10
FI925453L (fi) 1992-11-30
IL98273A0 (en) 1992-06-21
ES2099159T3 (es) 1997-05-16
SK281089B6 (sk) 2000-11-07
HU215258B (hu) 1998-11-30
CA2083396C (fr) 2006-09-19
EG19937A (en) 2000-12-31
CN1075113C (zh) 2001-11-21
CN1064313A (zh) 1992-09-09
IS1751B (is) 2000-07-21
BG97123A (bg) 1993-12-24
KR100212411B1 (en) 1999-08-02
NO322962B1 (no) 2006-12-18
AP9100270A0 (en) 1991-07-31
ZA913778B (en) 1992-02-26

Similar Documents

Publication Publication Date Title
TNSN91041A1 (fr) Nouveaux produits chimiques
ES2339441T3 (es) Colina axidasas.
AU667820B2 (en) Cytosine deaminase negative selection system for gene transfer techniques and therapies
EP0359771A4 (fr) Microorganismes actifs contre le coleopteres, compositions insecticides relatives et procedes de production et d'utilisation.
HUP0400261A2 (hu) Szubsztituált acetofenon sztereoszelektív redukciója
UA13380A (uk) Спосіб одержаhhя лейкоцитарhого іhтерфероhу
DK9787D0 (da) Bakterielle enzymer
SE8803071L (sv) Bakteriebehandling foer att bevara hoekvalitet genom att tillaegga genius bacillus mikroorganismer
HU906046D0 (en) Process for producing protein having urate-oxidase activity, gene coding that, vector of exprossion, micro organisms and transformed cells
US6022721A (en) Catalase, the gene thereof and composition comprising the same, and process for preparing catalase using genetic engineering technology
JPH09500264A (ja) Ｘｅｎｏｒｈａｂｄｕｓ ｎｅｍａｔｏｐｈｉｌｕｓの毒性遺伝子
Shaw et al. Nucleotide sequence of a novel arylesterase gene from Vibro mimicus and characterization of the enzyme expressed in Escherichia coli
DK0418945T3 (da) Forgreningsenzym og dets anvendelse
ATE227339T1 (de) Mikroorganismen zur biologischen bekämpfung von pflanzenkrankheiten
RU2002108174A (ru) Ген дезатуразы кислоты жирного ряда из растений
RU92016526A (ru) Белки, днк, векторы, фармацевтические композиции, применение белков, композиция детского питания, способы получения фармацевтической композиции и композиции для детского питания
EP0367767A4 (fr) Gene de toxine p-2 bacillus thuringiensis, proteine et compositions d'insecticide s'y rapportant.
DE69325169D1 (de) Verfahren zur herstellung von häm-proteinen
Islam et al. Chemotaxis between Vibrio cholerae O1 and a blue-green alga, Anabaena sp.
Lubke et al. Analysis and Optimization of Recombinant Protein Production in Escherichia coli using the Inducible pho A Promoter of the E. coli Alkaline Phosphatase
Koch Molecular analysis of the production of emulsifying compounds by Pseudomonas aeruginosa
RU2002100130A (ru) $$$6-ацетиленаза и $$$6-десатураза из ceratodon purpureus
Neilands Biochemistry and genetics of microbial iron assimilation
Evans et al. Bicarbonate assay and phosphoenolpyruvate carboxylase enzyme from hyphomicrobium